Mesoblast (MEOBF) Non-Current Deferred Tax Liability (2015 - 2021)
Mesoblast's (MEOBF) quarterly Non-Current Deferred Tax Liability came in at $7.9 million in Q4 2021, down 90.09% year-over-year from $80.1 million in Q4 2020, and up 5.08% quarter-over-quarter from $7.6 million in Q3 2021.
Analysis
Mesoblast (MEOBF) Non-Current Deferred Tax Liability (2015 - 2021) Analysis & Trends
Mesoblast has disclosed Non-Current Deferred Tax Liability across 7 years of filings, most recently posting $7.9 million for Q4 2021.
- In Q4 2021, Non-Current Deferred Tax Liability fell 90.09% year-over-year to $7.9 million; the TTM figure through Dec 2021 stood at $7.9 million (down 90.09% YoY), while the FY2021 annual figure was $8.5 million, up 1062.33% from the prior year.
- Non-Current Deferred Tax Liability came in at $7.9 million for Q4 2021 at Mesoblast, up from $7.6 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $80.2 million in Q1 2021 to a low of $730000.0 in Q2 2020.
- Average Non-Current Deferred Tax Liability over 5 years is $28.1 million, with a median of $17.9 million recorded in 2018.
- Year-over-year, Non-Current Deferred Tax Liability slumped 93.44% in 2020 and surged 1514.98% in 2021.
- Over 5 years, Non-Current Deferred Tax Liability stood at $23.9 million in 2017, then sank by 30.98% to $16.5 million in 2018, then slumped by 58.06% to $6.9 million in 2019, then jumped by 1057.43% to $80.1 million in 2020, then tumbled by 90.09% to $7.9 million in 2021.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $7.9 million in Q4 2021, $7.6 million in Q3 2021, and $8.5 million in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 7.56 Mn |
| Jun 30, 2021 | 8.49 Mn |
| Mar 31, 2021 | 80.20 Mn |
| Dec 31, 2020 | 80.12 Mn |
| Sep 30, 2020 | 79.91 Mn |
| Jun 30, 2020 | 730,000.00 |
| Mar 31, 2020 | 4.97 Mn |
| Dec 31, 2019 | 6.92 Mn |
| Sep 30, 2019 | 9.20 Mn |
| Jun 30, 2019 | 11.12 Mn |
| Mar 31, 2019 | 14.30 Mn |
| Dec 31, 2018 | 16.50 Mn |
| Sep 30, 2018 | 19.37 Mn |
| Jun 30, 2018 | 20.08 Mn |
| Mar 31, 2018 | 21.10 Mn |
| Dec 31, 2017 | 23.91 Mn |
| Sep 30, 2017 | 46.40 Mn |
| Jun 30, 2017 | 49.29 Mn |
| Mar 31, 2017 | 53.37 Mn |